<!DOCTYPE HTML>
<html lang="en">
<head>
<!-- Generated by javadoc (20) -->
<title>Source code</title>
<meta name="viewport" content="width=device-width, initial-scale=1">
<meta name="description" content="source: package: org.biopax.paxtools.model.level3, interface: FragmentFeature">
<meta name="generator" content="javadoc/SourceToHTMLConverter">
<link rel="stylesheet" type="text/css" href="../../../../../../stylesheet.css" title="Style">
</head>
<body class="source-page">
<main role="main">
<div class="source-container">
<pre><span class="source-line-no">001</span><span id="line-1">package org.biopax.paxtools.model.level3;</span>
<span class="source-line-no">002</span><span id="line-2"></span>
<span class="source-line-no">003</span><span id="line-3">/**</span>
<span class="source-line-no">004</span><span id="line-4"> * Definition: An entity feature that represents the resulting physical entity subsequent to a cleavage or</span>
<span class="source-line-no">005</span><span id="line-5"> * degradation event.</span>
<span class="source-line-no">006</span><span id="line-6"> *</span>
<span class="source-line-no">007</span><span id="line-7"> * Usage: Fragment Feature can be used to cover multiple types of modfications to the sequence of the physical</span>
<span class="source-line-no">008</span><span id="line-8"> * entity:</span>
<span class="source-line-no">009</span><span id="line-9"> * &lt;ul&gt;</span>
<span class="source-line-no">010</span><span id="line-10"> * &lt;li&gt;    A protein with a single cleavage site that converts the protein into two fragments (e.g. pro-insulin</span>
<span class="source-line-no">011</span><span id="line-11"> * converted to insulin and C-peptide). TODO: CV term for sequence fragment?  PSI-MI CV term for cleavage site?</span>
<span class="source-line-no">012</span><span id="line-12"> * &lt;li&gt;    A protein with two cleavage sites that removes an internal sequence e.g. an intein i.e. ABC -&amp;gt; A</span>
<span class="source-line-no">013</span><span id="line-13"> * &lt;li&gt;    Cleavage of a circular sequence e.g. a plasmid.</span>
<span class="source-line-no">014</span><span id="line-14"> * &lt;/ul&gt;</span>
<span class="source-line-no">015</span><span id="line-15"> * In the case of removal ( e.g. intron)  the fragment that is *removed* is specified in the feature location</span>
<span class="source-line-no">016</span><span id="line-16"> * property. In the case of a "cut" (e.g. restriction enzyme cut site) the location of the cut is specified instead.</span>
<span class="source-line-no">017</span><span id="line-17"> * Examples: Insulin Hormone</span>
<span class="source-line-no">018</span><span id="line-18"> */</span>
<span class="source-line-no">019</span><span id="line-19">public interface FragmentFeature extends EntityFeature</span>
<span class="source-line-no">020</span><span id="line-20">{</span>
<span class="source-line-no">021</span><span id="line-21"></span>
<span class="source-line-no">022</span><span id="line-22">}</span>




























































</pre>
</div>
</main>
</body>
</html>
